![Gwenan White](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Gwenan White worked as a Media Relations Contact at GSK Plc and as the Global Head-Pharma Communications at Novartis Pharma SAS. From 2021 to 2024, she served as the Executive VP-Communications & Public Affairs at Ipsen SA. Ms. White obtained an undergraduate degree from The University of Liverpool.
Anciens postes connus de Gwenan White
| Sociétés | Poste | Fin |
|---|---|---|
| IPSEN | Public Communications Contact | 19/08/2024 |
Novartis Pharma SAS
 Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Develops gene therapies for patients with rare and life-threatening neurological genetic diseases | Corporate Officer/Principal | - |
| GSK PLC | Public Communications Contact | - |
Formation de Gwenan White
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma SAS
Novartis Pharma SAS Pharmaceuticals: MajorHealth Technology Develops gene therapies for patients with rare and life-threatening neurological genetic diseases | Health Technology |
Choisissez Zonebourse 
